Home/Filings/4/0001493152-24-052262
4//SEC Filing

Patel Snehal 4

Accession 0001493152-24-052262

CIK 0001799788other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 4:19 PM ET

Size

8.2 KB

Accession

0001493152-24-052262

Insider Transaction Report

Form 4
Period: 2024-12-24
Patel Snehal
DirectorCEO and CFO10% Owner
Transactions
  • Award

    Stock Options

    2024-12-24+25,0082,247,462 total(indirect: By Spouse)
    Exercise: $12.16Exp: 2034-12-24Common Stock (25,008 underlying)
  • Award

    Stock Options

    2024-12-24+1,148,7232,222,454 total
    Exercise: $12.16Exp: 2034-12-24Common Stock (1,148,723 underlying)
Footnotes (2)
  • [F1]262,181 options are earned upon date of grant and 786,542 options are earned monthly over 36 months. 10% of the earned options vest if reporting person has been employed by Issuer between 1-2 years from grant date, 20% of the earned options vest if reporting person has been employed by Issuer between 2-3 years from grant date, 30% of the earned options vest if reporting person has been employed by Issuer between 3-4 years from grant date and the remaining earned options vest if reporting person has been employed by Issuer more than 4 years after grant date. 100,000 options are earned and vest upon date of grant.
  • [F2]6,252 options are earned and vest upon date of grant and the remainder are earned and vest monthly over 36 months.

Documents

1 file

Issuer

Greenwich LifeSciences, Inc.

CIK 0001799788

Entity typeother

Related Parties

1
  • filerCIK 0001806920

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 4:19 PM ET
Size
8.2 KB